ID   DYRK4_HUMAN             Reviewed;         520 AA.
AC   Q9NR20; A8K8F7; Q8NEF2; Q92631;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   15-FEB-2017, entry version 156.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 4;
DE            EC=2.7.12.1;
GN   Name=DYRK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ILE-95 AND
RP   SER-189.
RC   TISSUE=Brain, and Kidney;
RX   PubMed=11062477; DOI=10.1038/81664;
RA   White K.E., Evans W.E., O'Riordan J.L.H., Speer M.C., Econs M.J.,
RA   Lorenz-Depiereux B., Grabowski M., Meitinger T., Strom T.M.;
RT   "Autosomal dominant hypophosphataemic rickets is associated with
RT   mutations in FGF23.";
RL   Nat. Genet. 26:345-348(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-430 (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 280-520 (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=9748265; DOI=10.1074/jbc.273.40.25893;
RA   Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J.,
RA   Joost H.-G.;
RT   "Sequence characteristics, subcellular localization, and substrate
RT   specificity of DYRK-related kinases, a novel family of dual
RT   specificity protein kinases.";
RL   J. Biol. Chem. 273:25893-25902(1998).
RN   [5]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-133.
RX   PubMed=17292540; DOI=10.1016/j.mce.2006.12.041;
RA   Sacher F., Moeller C., Bone W., Gottwald U., Fritsch M.;
RT   "The expression of the testis-specific Dyrk4 kinase is highly
RT   restricted to step 8 spermatids but is not required for male fertility
RT   in mice.";
RL   Mol. Cell. Endocrinol. 267:80-88(2007).
RN   [6]
RP   ALTERNATIVE SPLICING (ISOFORMS 4 AND 5), SUBCELLULAR LOCATION (ISOFORM
RP   4), MUTAGENESIS OF TYR-264, AND PHOSPHORYLATION AT TYR-264.
RX   PubMed=21127067; DOI=10.1074/jbc.M110.157909;
RA   Papadopoulos C., Arato K., Lilienthal E., Zerweck J., Schutkowski M.,
RA   Chatain N., Muller-Newen G., Becker W., de la Luna S.;
RT   "Splice variants of the dual specificity tyrosine phosphorylation-
RT   regulated kinase 4 (DYRK4) differ in their subcellular localization
RT   and catalytic activity.";
RL   J. Biol. Chem. 286:5494-5505(2011).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-70.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Possible non-essential role in spermiogenesis.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- INTERACTION:
CC       Q92630:DYRK2; NbExp=3; IntAct=EBI-3914009, EBI-749432;
CC       O15344:MID1; NbExp=3; IntAct=EBI-3914009, EBI-2340316;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm
CC       {ECO:0000269|PubMed:17292540}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cytoplasm
CC       {ECO:0000269|PubMed:21127067}. Nucleus
CC       {ECO:0000269|PubMed:21127067}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NR20-1; Sequence=Displayed;
CC         Note=May be due to a competing acceptor splice site. No
CC         experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q9NR20-2; Sequence=VSP_013745;
CC       Name=3;
CC         IsoId=Q9NR20-3; Sequence=VSP_057132;
CC         Note=No experimental confirmation available.;
CC       Name=4; Synonyms=DYRK4-L;
CC         IsoId=Q9NR20-4; Sequence=VSP_057133;
CC         Note=Contains a bipartite nuclear localization signal at
CC         positions 19-37. {ECO:0000269|PubMed:21127067};
CC       Name=5;
CC         IsoId=Q9NR20-5; Sequence=VSP_057134;
CC         Note=Due to an alternative splicing donor site in exon 19.
CC         Markedly reduced enzymatic activity.
CC         {ECO:0000269|PubMed:21127067};
CC   -!- PTM: Autophosphorylation on Tyr-264 in the activation loop is
CC       required for kinase activity. {ECO:0000269|PubMed:21127067}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MNB/DYRK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF91393.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AK308260; Type=Frameshift; Positions=470; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF263541; AAF91393.1; ALT_INIT; mRNA.
DR   EMBL; AK292322; BAF85011.1; -; mRNA.
DR   EMBL; AK308260; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC031244; AAH31244.1; -; mRNA.
DR   EMBL; Y09305; CAA70488.1; -; mRNA.
DR   CCDS; CCDS8530.1; -. [Q9NR20-1]
DR   RefSeq; NP_003836.1; NM_003845.2. [Q9NR20-1]
DR   UniGene; Hs.439530; -.
DR   ProteinModelPortal; Q9NR20; -.
DR   SMR; Q9NR20; -.
DR   BioGrid; 114326; 16.
DR   IntAct; Q9NR20; 13.
DR   STRING; 9606.ENSP00000010132; -.
DR   BindingDB; Q9NR20; -.
DR   ChEMBL; CHEMBL1075115; -.
DR   GuidetoPHARMACOLOGY; 2013; -.
DR   iPTMnet; Q9NR20; -.
DR   PhosphoSitePlus; Q9NR20; -.
DR   BioMuta; DYRK4; -.
DR   DMDM; 68566308; -.
DR   EPD; Q9NR20; -.
DR   MaxQB; Q9NR20; -.
DR   PaxDb; Q9NR20; -.
DR   PeptideAtlas; Q9NR20; -.
DR   PRIDE; Q9NR20; -.
DR   DNASU; 8798; -.
DR   Ensembl; ENST00000010132; ENSP00000010132; ENSG00000010219. [Q9NR20-1]
DR   Ensembl; ENST00000540757; ENSP00000441755; ENSG00000010219. [Q9NR20-1]
DR   GeneID; 8798; -.
DR   KEGG; hsa:8798; -.
DR   UCSC; uc001qmx.5; human. [Q9NR20-1]
DR   CTD; 8798; -.
DR   GeneCards; DYRK4; -.
DR   HGNC; HGNC:3095; DYRK4.
DR   HPA; HPA028065; -.
DR   HPA; HPA056073; -.
DR   MIM; 609181; gene.
DR   neXtProt; NX_Q9NR20; -.
DR   OpenTargets; ENSG00000010219; -.
DR   PharmGKB; PA27552; -.
DR   eggNOG; KOG0667; Eukaryota.
DR   eggNOG; ENOG410XPET; LUCA.
DR   GeneTree; ENSGT00760000119032; -.
DR   HOGENOM; HOG000220863; -.
DR   HOVERGEN; HBG051426; -.
DR   InParanoid; Q9NR20; -.
DR   KO; K18669; -.
DR   PhylomeDB; Q9NR20; -.
DR   TreeFam; TF314624; -.
DR   SignaLink; Q9NR20; -.
DR   GenomeRNAi; 8798; -.
DR   PRO; PR:Q9NR20; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000010219; -.
DR   CleanEx; HS_DYRK4; -.
DR   ExpressionAtlas; Q9NR20; baseline and differential.
DR   Genevisible; Q9NR20; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    520       Dual specificity tyrosine-
FT                                phosphorylation-regulated kinase 4.
FT                                /FTId=PRO_0000085940.
FT   DOMAIN      104    400       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     110    118       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     183    186       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    230    230       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     133    133       ATP.
FT   MOD_RES     264    264       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:21127067}.
FT   VAR_SEQ       1      1       M -> MQLLPPPIRTGTKTQMDAKKPRKCDLTPFLVLKARK
FT                                KQKFTSAKVGSKLSVQIQKPPSNIKNSRMTQVFHKNTSVTS
FT                                LPFVDTKGKKNTVSFPHISKKVLLKSSLLYQENQAHNQM
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057132.
FT   VAR_SEQ       1      1       M -> MQLLPPPIRTGTKTQMDAKKPRKCDLTPFLVLKARK
FT                                KQKFTSAKGPTLSEIYMVGSKLSVQIQKPPSNIKNSRMTQV
FT                                FHKNTSVTSLPFVDTKGKKNTVSFPHISKKVLLKSSLLYQE
FT                                NQAHNQM (in isoform 4).
FT                                {ECO:0000303|PubMed:21127067}.
FT                                /FTId=VSP_057133.
FT   VAR_SEQ     380    382       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:21127067}.
FT                                /FTId=VSP_057134.
FT   VAR_SEQ     441    441       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11062477,
FT                                ECO:0000303|PubMed:9748265}.
FT                                /FTId=VSP_013745.
FT   VARIANT      61     61       A -> T (in dbSNP:rs12306130).
FT                                /FTId=VAR_033900.
FT   VARIANT      70     70       A -> S. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040465.
FT   VARIANT      95     95       V -> I (in dbSNP:rs746486416).
FT                                {ECO:0000269|PubMed:11062477}.
FT                                /FTId=VAR_010721.
FT   VARIANT     189    189       N -> S (in dbSNP:rs3741927).
FT                                {ECO:0000269|PubMed:11062477}.
FT                                /FTId=VAR_010722.
FT   VARIANT     454    454       D -> V (in dbSNP:rs1801016).
FT                                /FTId=VAR_014948.
FT   MUTAGEN     133    133       K->R: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:17292540}.
FT   MUTAGEN     264    264       Y->F: Abolishes kinase activity.
FT                                {ECO:0000269|PubMed:21127067}.
FT   CONFLICT    165    165       N -> I (in Ref. 2; BAF85011).
FT                                {ECO:0000305}.
SQ   SEQUENCE   520 AA;  59608 MW;  33FECD8249DDB223 CRC64;
     MPASELKASE IPFHPSIKTQ DPKAEEKSPK KQKVTLTAAE ALKLFKNQLS PYEQSEILGY
     AELWFLGLEA KKLDTAPEKF SKTSFDDEHG FYLKVLHDHI AYRYEVLETI GKGSFGQVAK
     CLDHKNNELV ALKIIRNKKR FHQQALMELK ILEALRKKDK DNTYNVVHMK DFFYFRNHFC
     ITFELLGINL YELMKNNNFQ GFSLSIVRRF TLSVLKCLQM LSVEKIIHCD LKPENIVLYQ
     KGQASVKVID FGSSCYEHQK VYTYIQSRFY RSPEVILGHP YDVAIDMWSL GCITAELYTG
     YPLFPGENEV EQLACIMEVL GLPPAGFIQT ASRRQTFFDS KGFPKNITNN RGKKRYPDSK
     DLTMVLKTYD TSFLDFLRRC LVWEPSLRMT PDQALKHAWI HQSRNLKPQP RPQTLRKSNS
     FFPSETRKDK VQGCHHSSRK ADEITKETTE KTKDSPTKHV QHSGDQQDCL QHGADTVQLP
     QLVDAPKKSE AAVGAEVSMT SPGQSKNFSL KNTNVLPPIV
//
